In order to develop a Clinical Pathways Strategy, your team needs to first understand the current landscape as it relates to therapeutic class. Innovation Partners’ Landscape Mapping provides insights into how various payer organizations are managing oncology, hematology and/or rare disease treatment options through clinical pathway relationships. Strategic research will illuminate how clinical pathways and payer agreements are impacting product access at the provider level, ultimately driving market share and product utilization/access down to the point of care.12